Testing effectiveness (Phase 2)Study completedNCT00106353What this trial is testingStudy Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid TumorsWho this might be right forAdenocarcinomaNeoplasms Pfizer 71
Early research (Phase 1)Study completedNCT01240538What this trial is testingViral Therapy in Treating Young Patients With Relapsed or Refractory Solid TumorsWho this might be right forUnspecified Childhood Solid Tumor, Protocol Specific National Cancer Institute (NCI) 26
Not applicableLooking for participantsNCT02530658What this trial is testingNext Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology PatientsWho this might be right forSolid, Liquid, Central Nervous System Tumors St. Jude Children's Research Hospital 2,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792What this trial is testingOral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsWho this might be right forMedullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more Eli Lilly and Company 36
Early research (Phase 1)Study completedNCT02076906What this trial is testingMR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsWho this might be right forRelapsed Pediatric Solid TumorsRefractory Pediatric Solid TumorsRhabdomyosarcoma+7 more AeRang Kim 7
Early research (Phase 1)WithdrawnNCT02800889What this trial is testingDose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory CancerWho this might be right forLymphomaSolid Tumor (Excluding CNS) CTI BioPharma
Testing effectiveness (Phase 2)Ended earlyNCT02541604What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid TumorsWho this might be right forSolid Tumor Hoffmann-La Roche 87
Early research (Phase 1)Study completedNCT02808650What this trial is testingPrexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsWho this might be right forChildhood Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+2 more Children's Oncology Group 30
Large-scale testing (Phase 3)Looking for participantsNCT06208917What this trial is testingOndansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in ChildrenWho this might be right forPediatric Solid Tumor, Unspecified, Protocol Specific Yizhuo Zhang 376
Early research (Phase 1)Looking for participantsNCT05608148What this trial is testingClinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid TumorsWho this might be right forRefractory/Relapse NeuroblastomaPediatric Solid Tumors Kyushu University 61
Early research (Phase 1)Study completedNCT00186979What this trial is testingStudy of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid TumorsWho this might be right forSolid Tumors St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06395103What this trial is testingSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Who this might be right forB-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more Merck Sharp & Dohme LLC 90
Not applicableLooking for participantsNCT06579469What this trial is testingProspective Evaluation Of Delayed Effects Of Pediatric Car T Cell TherapyWho this might be right forB-ALLHematologic MalignancySolid Tumor St. Jude Children's Research Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00069927What this trial is testingAdderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionWho this might be right forDepressionNeurotoxicityUnspecified Childhood Solid Tumor, Protocol Specific University of South Florida 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03834961What this trial is testingLarotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute LeukemiaWho this might be right forCentral Nervous System NeoplasmInfantile FibrosarcomaRecurrent Acute Leukemia+2 more Children's Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT02499861What this trial is testingPhase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory MalignanciesWho this might be right forCancer St. Justine's Hospital 6
Not applicableStudy completedNCT04471961What this trial is testingAnalyse of Tumour and Constitutional DNA for the Study of the Determinism in Child NeoplasiaWho this might be right forPediatric TumorFamilial CancerSolid Tumor, Childhood+1 more University Hospital, Montpellier 100
Testing effectiveness (Phase 2)Study completedNCT03245151What this trial is testingStudy of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System TumorsWho this might be right forRecurrent and Refractory Solid Tumors Eisai Inc. 64
Early research (Phase 1)WithdrawnNCT02557854What this trial is testingHIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid TumorsWho this might be right forRhabdomyosarcomaNeuroblastomaSarcoma+3 more Theodore Laetsch
Early research (Phase 1)Study completedNCT03936465What this trial is testingStudy of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric CancerWho this might be right forSolid Tumor, ChildhoodLymphomaBrain Tumor, Pediatric Dana-Farber Cancer Institute 41